Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B de Vries

Showing results (51-60 of 218) with videos related to

Pageof 22
Sort By:
Brain Research|June 22, 1999
Effects of handling on extracellular levels of glutamate and other amino acids in various areas of the brain measured by microdialysisW Timmerman, G Cisci, A Nap, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1997
Effect of machine perfusion preservation on delayed graft function in non-heart-beating donor kidneys--early resultsJ H Daemen, B de Vries, A P Oomen, et al.
Journal of Intellectual Disability Research : JIDR|February 1, 1994
The fragile-X syndrome: a growing gene causing familial intellectual disabilityL B De Vries, D J Halley, B A Oostra, et al.
European Journal of Pharmacology|June 17, 2000
A microdialysis study on the mechanism of action of gabapentinW Timmerman, M Bouma, J B De Vries, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 29, 2015
A patient with progressive dyspnoeaB P Adriaans, I V Samarska, B de Vries, et al.
Journal of Medicinal Chemistry|February 17, 2006
Extremely potent orally active benzo[g]quinoline analogue of the dopaminergic prodrug: 1-propyl-trans-2,3,4,4a,5,7,8,9,10,10a-decahydro-1H-benzo-[g]quinolin-6-one [corrected]Danyang Liu, Håkan V Wikström, Durk Dijkstra, et al.
European Journal of Pharmacology|February 26, 1985
N-methyl,N-propargyl-2-aminotetralins:novel dopamine agonists with monoamine oxidase inhibiting propertiesB Hazelhoff, J B De Vries, D Dijkstra, et al.
European Journal of Pharmacology|November 3, 1987
The effects of kainic acid and 6-hydroxydopamine lesions, metal ions and GTP on in vitro binding of the D-2 dopamine agonist, [3H]N-0437, to striatal membranesJ Van der Weide, J B De Vries, P G Tepper, et al.
Journal of Medicinal Chemistry|October 1, 1984
6,7-Dihydroxy-3-chromanamine: synthesis and pharmacological activity of an oxygen isostere of the dopamine agonist 6,7-dihydroxy-2-aminotetralinA S Horn, B Kaptein, T B Mulder, et al.
Life Sciences|October 28, 1985
HPLC-assay with electrochemical detection for the neurotoxin MPTP, its metabolite MPP+ and MPTP-analogues in biological samples after purification over Sephadex G10H Rollema, D S Fries, J B de Vries, et al.
Pageof 22

Showing results (51-60 of 218) with videos related to

Sort By:
Pageof 22
Brain Research|June 22, 1999
Effects of handling on extracellular levels of glutamate and other amino acids in various areas of the brain measured by microdialysisW Timmerman, G Cisci, A Nap, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1997
Effect of machine perfusion preservation on delayed graft function in non-heart-beating donor kidneys--early resultsJ H Daemen, B de Vries, A P Oomen, et al.
Journal of Intellectual Disability Research : JIDR|February 1, 1994
The fragile-X syndrome: a growing gene causing familial intellectual disabilityL B De Vries, D J Halley, B A Oostra, et al.
European Journal of Pharmacology|June 17, 2000
A microdialysis study on the mechanism of action of gabapentinW Timmerman, M Bouma, J B De Vries, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|May 29, 2015
A patient with progressive dyspnoeaB P Adriaans, I V Samarska, B de Vries, et al.
Journal of Medicinal Chemistry|February 17, 2006
Extremely potent orally active benzo[g]quinoline analogue of the dopaminergic prodrug: 1-propyl-trans-2,3,4,4a,5,7,8,9,10,10a-decahydro-1H-benzo-[g]quinolin-6-one [corrected]Danyang Liu, Håkan V Wikström, Durk Dijkstra, et al.
European Journal of Pharmacology|February 26, 1985
N-methyl,N-propargyl-2-aminotetralins:novel dopamine agonists with monoamine oxidase inhibiting propertiesB Hazelhoff, J B De Vries, D Dijkstra, et al.
European Journal of Pharmacology|November 3, 1987
The effects of kainic acid and 6-hydroxydopamine lesions, metal ions and GTP on in vitro binding of the D-2 dopamine agonist, [3H]N-0437, to striatal membranesJ Van der Weide, J B De Vries, P G Tepper, et al.
Journal of Medicinal Chemistry|October 1, 1984
6,7-Dihydroxy-3-chromanamine: synthesis and pharmacological activity of an oxygen isostere of the dopamine agonist 6,7-dihydroxy-2-aminotetralinA S Horn, B Kaptein, T B Mulder, et al.
Life Sciences|October 28, 1985
HPLC-assay with electrochemical detection for the neurotoxin MPTP, its metabolite MPP+ and MPTP-analogues in biological samples after purification over Sephadex G10H Rollema, D S Fries, J B de Vries, et al.
Pageof 22